{"nct_id":"NCT03390504","title":"A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2018-03-23","start_date_type":"ACTUAL","primary_completion_date":"2024-04-15","primary_completion_date_type":"ACTUAL","completion_date":"2026-11-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}